SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE was reported 470 times

SODIUM PHOSPHATE, DIBASIC, ANHYDROUS, POTASSIUM PHOSPHATE, MONOBASIC, AND SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MEDICAL DEVICE SITE PAPULE 1 0.1000
1 ARGININOSUCCINATE SYNTHETASE DEFICIENCY 1 0.0769
2 MYOCARDIAL STRAIN IMAGING ABNORMAL 1 0.0588
3 BURKHOLDERIA TEST POSITIVE 7 0.0565
4 HYPOPHOSPHATAEMIC RICKETS 1 0.0370
5 SYNOVIAL FLUID WHITE BLOOD CELLS POSITIVE 1 0.0333
6 EPIPHYSEAL INJURY 1 0.0294
7 ABORTION SPONTANEOUS COMPLETE 1 0.0256
8 FIBROSING COLONOPATHY 1 0.0250
9 MEDICAL DEVICE SITE MASS 1 0.0244
10 PHOSPHORUS METABOLISM DISORDER 1 0.0196
11 BULLOUS IMPETIGO 1 0.0167
12 LUNG ASSIST DEVICE THERAPY 1 0.0161
13 PSEUDOFOLLICULITIS 1 0.0159
14 LIVER IRON CONCENTRATION INCREASED 1 0.0123
15 PORTAL VEIN DILATATION 1 0.0112
16 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY 1 0.0109
17 THROMBOEMBOLECTOMY 1 0.0105
18 MEDICAL DEVICE SITE INJURY 1 0.0101
19 MEDICAL DEVICE SITE IRRITATION 1 0.0098
20 INCISION SITE CELLULITIS 1 0.0093
21 ADJUSTMENT DISORDER WITH MIXED ANXIETY AND DEPRESSED MOOD 1 0.0091
22 AMYLASE DECREASED 1 0.0090
23 POLYOMAVIRUS TEST POSITIVE 1 0.0085
24 PARANEOPLASTIC PEMPHIGUS 1 0.0077
25 OROPHARYNGEAL ERYTHEMA 1 0.0068
26 PERITONEAL HAEMATOMA 1 0.0067
27 ASPERGILLUS TEST POSITIVE 2 0.0065
28 LOWER RESPIRATORY TRACT INFECTION FUNGAL 2 0.0051
29 VITAMIN C DEFICIENCY 1 0.0051
30 DEVICE COLOUR ISSUE 2 0.0050
31 STAPHYLOCOCCAL SCALDED SKIN SYNDROME 1 0.0044
32 GRAFT VERSUS HOST DISEASE IN EYE 1 0.0043
33 TYPE IIA HYPERLIPIDAEMIA 1 0.0043
34 HYPONATRAEMIC SEIZURE 1 0.0039
35 INGUINAL MASS 1 0.0039
36 ECZEMA EYELIDS 2 0.0036
37 FANCONI SYNDROME ACQUIRED 6 0.0034
38 CREATININE URINE INCREASED 1 0.0033
39 RENAL HYPERTENSION 1 0.0032
40 FLUID REPLACEMENT 1 0.0030
41 MULTIPLE SYSTEM ATROPHY 1 0.0028
42 RADIATION OESOPHAGITIS 1 0.0026
43 NEUROBLASTOMA 1 0.0026
44 CEREBRAL VENTRICLE DILATATION 3 0.0026
45 PRODUCT BARCODE ISSUE 1 0.0026
46 LIMB AMPUTATION 1 0.0025
47 BONE DENSITY INCREASED 1 0.0025
48 BLOOD PHOSPHORUS DECREASED 9 0.0025
49 PSEUDOMONAL BACTERAEMIA 2 0.0023
50 OESOPHAGEAL DILATATION 1 0.0023
51 HYPERLEUKOCYTOSIS 2 0.0023
52 METASTASES TO PANCREAS 1 0.0023
53 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 1 0.0022
54 INTUSSUSCEPTION 2 0.0021
55 ELECTROLYTE DEPLETION 1 0.0020
56 INFUSION SITE CELLULITIS 1 0.0019
57 POLYOMAVIRUS VIRAEMIA 2 0.0019
58 MEDICAL DEVICE CHANGE 1 0.0019
59 HYPERTENSIVE NEPHROPATHY 2 0.0019
60 EPHELIDES 1 0.0019
61 STOMA SITE IRRITATION 1 0.0018
62 KIDNEY ENLARGEMENT 2 0.0018
63 INTERLEUKIN LEVEL INCREASED 1 0.0018
64 LIFE EXPECTANCY SHORTENED 1 0.0018
65 CELLULITIS ORBITAL 1 0.0017
66 GRAFT COMPLICATION 1 0.0017
67 FULL BLOOD COUNT INCREASED 2 0.0017
68 EXCESSIVE CERUMEN PRODUCTION 1 0.0016
69 PANCREATIC NEUROENDOCRINE TUMOUR 1 0.0016
70 SLOW RESPONSE TO STIMULI 2 0.0015
71 CHONDROCALCINOSIS 1 0.0015
72 STOMA SITE REACTION 1 0.0015
73 INCISIONAL HERNIA 2 0.0014
74 ENDOTRACHEAL INTUBATION 4 0.0014
75 BLOOD ELECTROLYTES DECREASED 2 0.0014
76 HYPERPHOSPHATAEMIA 3 0.0014
77 CHYLOTHORAX 1 0.0014
78 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
79 STOMA SITE PAIN 2 0.0014
80 HYPOPHOSPHATAEMIA 10 0.0014
81 AMINO ACID LEVEL INCREASED 1 0.0013
82 STOMA SITE INFLAMMATION 1 0.0013
83 STOMA SITE HAEMORRHAGE 2 0.0013
84 BLOOD FIBRINOGEN INCREASED 1 0.0013
85 PHARYNGEAL PARAESTHESIA 2 0.0013
86 DYSCHROMATOPSIA 1 0.0012
87 ADRENAL MASS 1 0.0012
88 STARVATION 1 0.0012
89 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 7 0.0012
90 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
91 DEVICE LOOSENING 1 0.0012
92 KIDNEY FIBROSIS 2 0.0012
93 ACUTE CHEST SYNDROME 1 0.0011
94 HILAR LYMPHADENOPATHY 1 0.0011
95 RENAL TUBULAR ATROPHY 1 0.0011
96 MITRAL VALVE DISEASE 2 0.0011
97 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
98 ANAEMIA OF CHRONIC DISEASE 1 0.0011
99 STOMA SITE DISCHARGE 3 0.0011
100 STOMA SITE ERYTHEMA 2 0.0011
101 PYELOCALIECTASIS 1 0.0010
102 FOREIGN BODY IN EYE 1 0.0010
103 AUTONOMIC NEUROPATHY 1 0.0010
104 STOMA COMPLICATION 1 0.0010
105 NEUTROPENIC COLITIS 2 0.0010
106 PERTUSSIS 1 0.0010
107 BLAST CELL COUNT INCREASED 1 0.0010
108 RESPIRATORY RATE DECREASED 3 0.0010
109 METASTASES TO PLEURA 1 0.0010
110 HYPOPERFUSION 1 0.0010
111 EYE CONTUSION 2 0.0009
112 POST PROCEDURAL SWELLING 1 0.0009
113 PRODUCT LOT NUMBER ISSUE 2 0.0009
114 AORTIC DILATATION 1 0.0009
115 INCISION SITE PAIN 1 0.0009
116 ESCHERICHIA BACTERAEMIA 2 0.0008
117 DEVICE DISPENSING ERROR 1 0.0008
118 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
119 INTRA-ABDOMINAL HAEMATOMA 1 0.0008
120 BLOOD UREA DECREASED 1 0.0008
121 HYPERPARATHYROIDISM SECONDARY 2 0.0008
122 HEPATOSPLENOMEGALY 2 0.0008
123 HYPOVITAMINOSIS 1 0.0008
124 VULVOVAGINAL CANDIDIASIS 1 0.0007
125 TONGUE DRY 1 0.0007
126 THROMBOCYTOPENIC PURPURA 1 0.0007
127 CLUSTER HEADACHE 1 0.0007
128 JOINT INSTABILITY 1 0.0007
129 THERAPEUTIC PROCEDURE 1 0.0007
130 LUNG CONSOLIDATION 2 0.0007
131 FANCONI SYNDROME 1 0.0007
132 CATAPLEXY 1 0.0007
133 INSULIN-LIKE GROWTH FACTOR INCREASED 1 0.0007
134 NOROVIRUS INFECTION 1 0.0007
135 BILIARY DILATATION 1 0.0007
136 GENITAL PAIN 1 0.0007
137 KNEE DEFORMITY 1 0.0007
138 ANGIOPLASTY 1 0.0007
139 MENTAL FATIGUE 1 0.0007
140 EPICONDYLITIS 1 0.0007
141 VASCULAR DEVICE INFECTION 3 0.0007
142 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
143 NEPHROGENIC ANAEMIA 3 0.0006
144 OSTEOMALACIA 1 0.0006
145 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
146 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
147 KIDNEY TRANSPLANT REJECTION 3 0.0006
148 PNEUMONIA LEGIONELLA 1 0.0006
149 CUSHINGOID 2 0.0006
150 IMMUNE-MEDIATED MYOCARDITIS 1 0.0006
151 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
152 LINEAR IGA DISEASE 1 0.0006
153 SALMONELLOSIS 1 0.0006
154 LAZINESS 1 0.0006
155 PSEUDOMONAL SEPSIS 1 0.0006
156 KYPHOSIS 1 0.0006
157 FIBRIN D DIMER INCREASED 2 0.0006
158 VOCAL CORD PARALYSIS 1 0.0006
159 CYTOKINE RELEASE SYNDROME 11 0.0005
160 OESOPHAGEAL SPASM 1 0.0005
161 DISORGANISED SPEECH 1 0.0005
162 BLOOD IRON INCREASED 1 0.0005
163 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
164 GINGIVAL RECESSION 1 0.0005
165 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
166 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
167 ORAL INFECTION 2 0.0005
168 PNEUMONIA FUNGAL 2 0.0005
169 PNEUMONIA STAPHYLOCOCCAL 1 0.0005
170 CEREBRAL ATROPHY 2 0.0005
171 TRIGEMINAL NEURALGIA 2 0.0005
172 NIPPLE PAIN 1 0.0005
173 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
174 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
175 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
176 BACTERIAL TEST POSITIVE 1 0.0004
177 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
178 METASTASES TO MENINGES 1 0.0004
179 LICHENOID KERATOSIS 1 0.0004
180 PANCREATITIS NECROTISING 1 0.0004
181 CYTOMEGALOVIRUS COLITIS 1 0.0004
182 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
183 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
184 PRODUCT PACKAGING CONFUSION 1 0.0004
185 BRONCHITIS CHRONIC 1 0.0004
186 RETINAL TEAR 1 0.0004
187 DENTAL OPERATION 1 0.0004
188 HOSPICE CARE 4 0.0004
189 HYPERVOLAEMIA 2 0.0004
190 SUFFOCATION FEELING 1 0.0004
191 STEM CELL TRANSPLANT 1 0.0004
192 ECONOMIC PROBLEM 6 0.0004
193 TROPONIN INCREASED 3 0.0004
194 CANCER PAIN 1 0.0004
195 BLOOD CHLORIDE DECREASED 1 0.0004
196 LIPOMA 1 0.0004
197 CATHETER SITE PAIN 1 0.0004
198 ANHEDONIA 10 0.0004
199 EXFOLIATIVE RASH 1 0.0004
200 SERUM FERRITIN INCREASED 2 0.0004
201 GASTROINTESTINAL STROMAL TUMOUR 1 0.0004
202 WEIGHT BEARING DIFFICULTY 1 0.0004
203 BLOOD PHOSPHORUS INCREASED 1 0.0004
204 HYPERKERATOSIS 2 0.0004
205 PROSTATIC DISORDER 2 0.0004
206 CHOLECYSTITIS INFECTIVE 1 0.0004
207 MALNUTRITION 4 0.0004
208 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
209 TUMOUR HAEMORRHAGE 1 0.0004
210 LIP PAIN 1 0.0003
211 ADENOVIRUS INFECTION 1 0.0003
212 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
213 DEVICE POWER SOURCE ISSUE 1 0.0003
214 NECK INJURY 1 0.0003
215 GROWTH RETARDATION 1 0.0003
216 BACTERAEMIA 4 0.0003
217 METABOLIC ENCEPHALOPATHY 1 0.0003
218 PLASMA CELL MYELOMA 13 0.0003
219 EMERGENCY CARE 1 0.0003
220 EYE INJURY 1 0.0003
221 MEDICAL DEVICE DISCOMFORT 1 0.0003
222 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
223 BLOOD BLISTER 1 0.0003
224 INFUSION SITE SWELLING 2 0.0003
225 BLADDER PAIN 1 0.0003
226 ORTHOPNOEA 1 0.0003
227 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
228 BK VIRUS INFECTION 1 0.0003
229 TASTE DISORDER 6 0.0003
230 CLOSTRIDIAL INFECTION 1 0.0003
231 HEPATIC CYST 1 0.0003
232 PETECHIAE 3 0.0003
233 BRONCHIOLITIS 1 0.0003
234 EMBOLIC STROKE 1 0.0003
235 GOUT 5 0.0003
236 GRAFT VERSUS HOST DISEASE 2 0.0003
237 RENAL TRANSPLANT 1 0.0003
238 DEVICE KINK 1 0.0003
239 AMYLASE INCREASED 1 0.0003
240 OSTEOPENIA 4 0.0003
241 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
242 GINGIVAL DISORDER 1 0.0003
243 RHINOVIRUS INFECTION 1 0.0003
244 EPIGASTRIC DISCOMFORT 1 0.0003
245 GASTROINTESTINAL INFLAMMATION 2 0.0003
246 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
247 GINGIVAL PAIN 2 0.0003
248 HYPERPHAGIA 1 0.0003
249 BLOOD DISORDER 2 0.0002
250 VITAMIN B12 DEFICIENCY 1 0.0002
251 RECURRENT CANCER 1 0.0002
252 PERIPHERAL ISCHAEMIA 1 0.0002
253 HYPERURICAEMIA 1 0.0002
254 SPINAL STENOSIS 1 0.0002
255 EMBOLISM 2 0.0002
256 INTESTINAL STENOSIS 1 0.0002
257 LIP OEDEMA 1 0.0002
258 MUSCLE FATIGUE 1 0.0002
259 FACIAL PARALYSIS 2 0.0002
260 LUNG NEOPLASM 1 0.0002
261 PRODUCT DISPENSING ISSUE 1 0.0002
262 INFUSION SITE PAIN 3 0.0002
263 SKIN HYPERPIGMENTATION 2 0.0002
264 ABNORMAL SENSATION IN EYE 1 0.0002
265 METASTATIC NEOPLASM 1 0.0002
266 BLOOD MAGNESIUM DECREASED 2 0.0002
267 HORDEOLUM 1 0.0002
268 TUMOUR LYSIS SYNDROME 2 0.0002
269 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
270 ABDOMINAL ABSCESS 1 0.0002
271 ANAL INCONTINENCE 2 0.0002
272 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
273 ISCHAEMIA 1 0.0002
274 INCREASED TENDENCY TO BRUISE 2 0.0002
275 CONJUNCTIVITIS 4 0.0002
276 UMBILICAL HERNIA 1 0.0002
277 SKIN ABRASION 1 0.0002
278 IMPAIRED QUALITY OF LIFE 3 0.0002
279 EYE IRRITATION 12 0.0002
280 HUMERUS FRACTURE 1 0.0002
281 HYPERCHOLESTEROLAEMIA 2 0.0002
282 ENTEROCOCCAL INFECTION 1 0.0002
283 VITAMIN D DEFICIENCY 2 0.0002
284 HORMONE LEVEL ABNORMAL 1 0.0002
285 STAPHYLOCOCCAL SEPSIS 1 0.0002
286 PULMONARY MASS 3 0.0002
287 VEIN DISORDER 1 0.0002
288 HYPOXIA 7 0.0002
289 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
290 FEBRILE NEUTROPENIA 13 0.0002
291 FEMORAL NECK FRACTURE 1 0.0002
292 HYPOKALAEMIA 9 0.0002
293 MUSCULOSKELETAL CHEST PAIN 3 0.0002
294 ANKLE FRACTURE 3 0.0002
295 TONSILLITIS 1 0.0002
296 MALABSORPTION 1 0.0002
297 FULL BLOOD COUNT ABNORMAL 2 0.0002
298 FOOD POISONING 1 0.0002
299 COMPRESSION FRACTURE 1 0.0002
300 PRODUCT SIZE ISSUE 1 0.0002
301 GINGIVITIS 1 0.0002
302 DECREASED ACTIVITY 2 0.0002
303 ERYTHEMA OF EYELID 1 0.0002
304 CHRONIC KIDNEY DISEASE 14 0.0002
305 ASPIRATION 2 0.0002
306 DENTAL CARIES 2 0.0002
307 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
308 BLOOD CALCIUM DECREASED 2 0.0002
309 HERPES VIRUS INFECTION 1 0.0002
310 BLOOD URIC ACID INCREASED 1 0.0002
311 ELECTROLYTE IMBALANCE 2 0.0002
312 STRESS CARDIOMYOPATHY 1 0.0002
313 NEUROTOXICITY 3 0.0002
314 HYPOVOLAEMIA 1 0.0002
315 URINE ODOUR ABNORMAL 1 0.0002
316 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
317 CHOLECYSTITIS 2 0.0002
318 ODYNOPHAGIA 1 0.0002
319 PROTHROMBIN TIME PROLONGED 1 0.0002
320 TOOTHACHE 3 0.0002
321 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
322 END STAGE RENAL DISEASE 3 0.0002
323 SCOLIOSIS 1 0.0002
324 BLOOD SODIUM DECREASED 3 0.0002
325 BRAIN OEDEMA 2 0.0002
326 FOREIGN BODY SENSATION IN EYES 1 0.0002
327 ENTERITIS 1 0.0002
328 ACUTE RESPIRATORY FAILURE 3 0.0002
329 NODULE 2 0.0002
330 PRODUCT PREPARATION ISSUE 1 0.0002
331 BEDRIDDEN 2 0.0002
332 ORAL CANDIDIASIS 2 0.0002
333 PULMONARY CONGESTION 2 0.0002
334 WALKING AID USER 1 0.0002
335 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
336 RESPIRATORY FAILURE 11 0.0002
337 TERMINAL STATE 1 0.0001
338 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
339 BREAST MASS 1 0.0001
340 POSTOPERATIVE WOUND INFECTION 1 0.0001
341 ULCER HAEMORRHAGE 1 0.0001
342 GINGIVAL BLEEDING 2 0.0001
343 EYE MOVEMENT DISORDER 1 0.0001
344 OSTEOPOROSIS 6 0.0001
345 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
346 LYMPHOEDEMA 1 0.0001
347 ENCEPHALITIS 1 0.0001
348 HYPOMAGNESAEMIA 2 0.0001
349 PANCYTOPENIA 8 0.0001
350 DEFAECATION URGENCY 1 0.0001
351 BLOOD TEST ABNORMAL 2 0.0001
352 PARAESTHESIA ORAL 2 0.0001
353 DEEP VEIN THROMBOSIS 9 0.0001
354 VISUAL FIELD DEFECT 1 0.0001
355 DERMATITIS BULLOUS 1 0.0001
356 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
357 PRODUCT PRESCRIBING ISSUE 3 0.0001
358 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
359 FLUID OVERLOAD 2 0.0001
360 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
361 CEREBRAL DISORDER 1 0.0001
362 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
363 BONE LOSS 2 0.0001
364 BLOOD POTASSIUM DECREASED 4 0.0001
365 CHROMATURIA 3 0.0001
366 PAROSMIA 1 0.0001
367 LIPASE INCREASED 1 0.0001
368 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
369 APHTHOUS ULCER 1 0.0001
370 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
371 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
372 EJECTION FRACTION DECREASED 2 0.0001
373 HYPOALBUMINAEMIA 1 0.0001
374 PELVIC FRACTURE 1 0.0001
375 PULMONARY HAEMORRHAGE 1 0.0001
376 BONE DENSITY DECREASED 4 0.0001
377 BRAIN FOG 2 0.0001
378 DEHYDRATION 17 0.0001
379 FURUNCLE 1 0.0001
380 NASAL DISCOMFORT 1 0.0001
381 SCIATICA 2 0.0001
382 ATRIAL FLUTTER 1 0.0001
383 TRANSPLANT REJECTION 1 0.0001
384 HYPONATRAEMIA 7 0.0001
385 DYSKINESIA 5 0.0001
386 ENCEPHALOPATHY 3 0.0001
387 UPPER-AIRWAY COUGH SYNDROME 1 0.0001
388 DRUG LEVEL INCREASED 2 0.0001
389 HEMIPLEGIA 1 0.0001
390 COAGULOPATHY 2 0.0001
391 TYPE 2 DIABETES MELLITUS 4 0.0001
392 PSYCHOLOGICAL TRAUMA 1 0.0001
393 PLEURAL EFFUSION 7 0.0001
394 URINE OUTPUT DECREASED 1 0.0001
395 HEART RATE DECREASED 4 0.0001
396 LYMPHOCYTE COUNT DECREASED 2 0.0001
397 PLATELET COUNT DECREASED 12 0.0001
398 GALLBLADDER DISORDER 2 0.0001
399 LIMB INJURY 3 0.0001
400 PNEUMONITIS 3 0.0001
401 RESTLESS LEGS SYNDROME 2 0.0001
402 C-REACTIVE PROTEIN INCREASED 4 0.0001
403 HYPERGLYCAEMIA 4 0.0001
404 BONE DISORDER 2 0.0001
405 RETINAL DETACHMENT 1 0.0001
406 NERVE COMPRESSION 1 0.0001
407 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
408 MENTAL STATUS CHANGES 3 0.0001
409 ERYTHEMA MULTIFORME 1 0.0001
410 NEPHROPATHY 1 0.0001
411 DIARRHOEA HAEMORRHAGIC 1 0.0001
412 EPISTAXIS 8 0.0001
413 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
414 LEUKAEMIA 1 0.0001
415 PRODUCT PACKAGING ISSUE 1 0.0001
416 NEUROPATHY PERIPHERAL 10 0.0001
417 HYPERSOMNIA 3 0.0001
418 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
419 ATELECTASIS 1 0.0001
420 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
421 PHARYNGEAL SWELLING 1 0.0001
422 RENAL TUBULAR NECROSIS 1 0.0001
423 KIDNEY INFECTION 2 0.0001
424 LABORATORY TEST ABNORMAL 3 0.0001
425 URINARY INCONTINENCE 3 0.0001
426 LIGAMENT SPRAIN 1 0.0001
427 BLADDER DISORDER 1 0.0001
428 INABILITY TO AFFORD MEDICATION 1 0.0001
429 UPPER LIMB FRACTURE 2 0.0001
430 SALIVARY HYPERSECRETION 1 0.0001
431 BRAIN INJURY 1 0.0001
432 DRY THROAT 1 0.0001
433 TOOTH ABSCESS 1 0.0001
434 MOTOR DYSFUNCTION 1 0.0001
435 ACUTE KIDNEY INJURY 15 0.0001
436 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
437 RIB FRACTURE 2 0.0001
438 TOOTH LOSS 2 0.0001
439 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
440 DERMATITIS 2 0.0001
441 INCONTINENCE 1 0.0001
442 PANCREATITIS 5 0.0001
443 JOINT DISLOCATION 1 0.0001
444 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
445 SKIN LACERATION 1 0.0001
446 PULMONARY THROMBOSIS 1 0.0001
447 OESOPHAGITIS 1 0.0001
448 EMOTIONAL DISTRESS 11 0.0001
449 SKIN DISORDER 3 0.0001
450 TOOTH DISORDER 2 0.0001
451 RASH MACULO-PAPULAR 2 0.0001
452 ORAL PAIN 2 0.0001
453 EYE PRURITUS 3 0.0001
454 SKIN INFECTION 1 0.0001
455 NEPHROPATHY TOXIC 1 0.0001
456 THERAPY NON-RESPONDER 4 0.0001
457 OXYGEN SATURATION DECREASED 5 0.0001
458 STATUS EPILEPTICUS 1 0.0001
459 DERMATITIS CONTACT 1 0.0001
460 HAEMATURIA 3 0.0001
461 GASTROOESOPHAGEAL REFLUX DISEASE 7 0.0001
462 SEIZURE 10 0.0001
463 PERICARDIAL EFFUSION 2 0.0001
464 ABDOMINAL DISTENSION 9 0.0001
465 COVID-19 PNEUMONIA 1 0.0001
466 ANAEMIA 16 0.0001
467 HYPERLIPIDAEMIA 1 0.0001
468 RENAL FAILURE 11 0.0001
469 BURSITIS 1 0.0001
470 ADRENAL INSUFFICIENCY 1 0.0001
471 PRESYNCOPE 2 0.0001
472 CYTOPENIA 1 0.0001
473 SPINAL OPERATION 1 0.0001
474 HYPERCALCAEMIA 1 0.0001
475 GENERALISED OEDEMA 1 0.0001
476 SEPSIS 9 0.0001
477 EYE SWELLING 3 0.0001
478 ILEUS 1 0.0001
479 HAIR COLOUR CHANGES 1 0.0001
480 PNEUMONIA ASPIRATION 2 0.0001
481 DERMATITIS ALLERGIC 1 0.0001
482 COLITIS 3 0.0001
483 MUSCLE ATROPHY 1 0.0001
484 FLUID RETENTION 4 0.0001
485 SKIN ULCER 2 0.0001
486 URINARY TRACT INFECTION 13 0.0001
487 SARS-COV-2 TEST POSITIVE 1 0.0001
488 BLOOD PRESSURE DECREASED 5 0.0001
489 JOINT RANGE OF MOTION DECREASED 1 0.0001
490 DIARRHOEA 48 0.0001
491 SINUS CONGESTION 1 0.0001
492 PRODUCT TASTE ABNORMAL 1 0.0001
493 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
494 OEDEMA 4 0.0001
495 CORONARY ARTERY OCCLUSION 1 0.0001
496 SKIN LESION 2 0.0001
497 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
498 FEELING COLD 2 0.0001
499 INFLUENZA 8 0.0001
500 COORDINATION ABNORMAL 1 0.0001
501 RENAL IMPAIRMENT 6 0.0001
502 DEVICE OCCLUSION 1 0.0001
503 SEASONAL ALLERGY 1 0.0001
504 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
505 MUSCULAR WEAKNESS 8 0.0001
506 SUBDURAL HAEMATOMA 1 0.0001
507 CARDIOGENIC SHOCK 1 0.0001
508 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
509 INFECTION 10 0.0001
510 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
511 APATHY 1 0.0001
512 GASTROENTERITIS 1 0.0001
513 DYSSTASIA 2 0.0001
514 BONE PAIN 4 0.0001
515 ASCITES 2 0.0001
516 CARDIOMYOPATHY 1 0.0001
517 TACHYCARDIA 6 0.0001
518 RENAL INJURY 2 0.0001
519 CATARACT 4 0.0001
520 COLON CANCER 1 0.0001
521 IMMUNODEFICIENCY 1 0.0001
522 PULMONARY OEDEMA 3 0.0001
523 HOT FLUSH 5 0.0001
524 HYPOAESTHESIA ORAL 1 0.0001
525 HEPATIC FAILURE 2 0.0001
526 CORONARY ARTERY DISEASE 2 0.0001
527 BLOOD COUNT ABNORMAL 1 0.0001
528 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
529 NEPHROLITHIASIS 3 0.0001
530 LYMPHOMA 1 0.0001
531 FEMUR FRACTURE 2 0.0001
532 BASAL CELL CARCINOMA 1 0.0001
533 CYANOSIS 1 0.0001
534 PYREXIA 22 0.0001
535 SICKLE CELL ANAEMIA WITH CRISIS 1 0.0001
536 HEAD INJURY 2 0.0001
537 PNEUMOTHORAX 1 0.0001
538 CONTUSION 6 0.0001
539 SENSORY DISTURBANCE 1 0.0001
540 ATRIAL FIBRILLATION 6 0.0001
541 BLOOD POTASSIUM INCREASED 1 0.0001
542 BACK DISORDER 1 0.0001
543 HYPERTENSION 13 0.0001
544 METASTASES TO BONE 1 0.0001
545 IMPAIRED HEALING 2 0.0001
546 OSTEONECROSIS 2 0.0001
547 MULTIPLE FRACTURES 1 0.0001
548 VENTRICULAR TACHYCARDIA 1 0.0001
549 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
550 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
551 URINARY RETENTION 2 0.0001
552 GAIT INABILITY 2 0.0001
553 BLOOD UREA INCREASED 1 0.0001
554 PERICARDITIS 1 0.0001
555 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
556 FACE OEDEMA 1 0.0001
557 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
558 GASTRIC DISORDER 2 0.0001
559 ILLNESS 6 0.0001
560 MUSCULOSKELETAL DISCOMFORT 1 0.0001
561 ORTHOSTATIC HYPOTENSION 1 0.0001
562 ECZEMA 3 0.0001
563 RASH MACULAR 2 0.0001
564 MUSCULOSKELETAL STIFFNESS 5 0.0001
565 EOSINOPHILIA 1 0.0001
566 COVID-19 10 0.0001
567 SLEEP DISORDER 4 0.0001
568 LYMPHADENOPATHY 2 0.0001
569 DECREASED APPETITE 13 0.0001
570 CEREBRAL HAEMORRHAGE 2 0.0001
571 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
572 MYELOSUPPRESSION 2 0.0001
573 GASTROENTERITIS VIRAL 1 0.0001
574 CONSTIPATION 12 0.0001
575 FALL 18 0.0001
576 WEIGHT DECREASED 15 0.0001
577 ABDOMINAL DISCOMFORT 9 0.0001
578 THROMBOCYTOPENIA 6 0.0001
579 HEPATIC CIRRHOSIS 1 0.0001
580 EYE PAIN 3 0.0001
581 PHOTOPHOBIA 1 0.0001
582 DYSARTHRIA 2 0.0001
583 HYPOCALCAEMIA 1 0.0001
584 FOOT FRACTURE 1 0.0001
585 PROTEINURIA 1 0.0001
586 SLEEP APNOEA SYNDROME 1 0.0001
587 INCREASED APPETITE 1 0.0001
588 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
589 LOWER LIMB FRACTURE 1 0.0001
590 ERUCTATION 1 0.0001
591 NEUTROPENIA 7 0.0001
592 PALPITATIONS 6 0.0001
593 ORAL HERPES 1 0.0001
594 DISEASE PROGRESSION 6 0.0001
595 SINUS DISORDER 1 0.0001
596 CARDIAC FAILURE 4 0.0000
597 JOINT SWELLING 6 0.0000
598 CONFUSIONAL STATE 8 0.0000
599 PNEUMONIA 16 0.0000
600 OEDEMA PERIPHERAL 6 0.0000
601 ANXIETY 14 0.0000
602 DISCOMFORT 3 0.0000
603 NEUTROPHIL COUNT DECREASED 2 0.0000
604 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
605 HAEMOGLOBIN DECREASED 5 0.0000
606 PULMONARY HYPERTENSION 1 0.0000
607 MOUTH ULCERATION 1 0.0000
608 ABDOMINAL PAIN 11 0.0000
609 PAIN 29 0.0000
610 IMPAIRED WORK ABILITY 1 0.0000
611 LIVER FUNCTION TEST INCREASED 1 0.0000
612 RECTAL HAEMORRHAGE 2 0.0000
613 POOR QUALITY SLEEP 1 0.0000
614 SEPTIC SHOCK 2 0.0000
615 MENTAL DISORDER 2 0.0000
616 BLOOD CREATININE INCREASED 3 0.0000
617 INTENTIONAL PRODUCT MISUSE 4 0.0000
618 ASTHENIA 17 0.0000
619 STEVENS-JOHNSON SYNDROME 1 0.0000
620 FATIGUE 35 0.0000
621 GLOSSODYNIA 1 0.0000
622 RASH PAPULAR 1 0.0000
623 HEART RATE IRREGULAR 1 0.0000
624 DYSPNOEA 25 0.0000
625 PRODUCT AVAILABILITY ISSUE 1 0.0000
626 MUSCLE TWITCHING 1 0.0000
627 RENAL DISORDER 2 0.0000
628 SWELLING 4 0.0000
629 VOMITING 20 0.0000
630 OCULAR HYPERAEMIA 2 0.0000
631 RASH ERYTHEMATOUS 2 0.0000
632 BLOOD PRESSURE FLUCTUATION 1 0.0000
633 BLOOD GLUCOSE DECREASED 2 0.0000
634 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
635 DIABETIC KETOACIDOSIS 1 0.0000
636 INTERSTITIAL LUNG DISEASE 2 0.0000
637 HYPOGLYCAEMIA 2 0.0000
638 PRODUCT DOSE OMISSION ISSUE 12 0.0000
639 LIVER INJURY 1 0.0000
640 DYSPEPSIA 4 0.0000
641 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
642 AGEUSIA 1 0.0000
643 SYNCOPE 4 0.0000
644 UNEVALUABLE EVENT 3 0.0000
645 HAEMATEMESIS 1 0.0000
646 HYPOPHAGIA 1 0.0000
647 HOSPITALISATION 6 0.0000
648 ERECTILE DYSFUNCTION 1 0.0000
649 DRUG RESISTANCE 1 0.0000
650 ABDOMINAL PAIN UPPER 8 0.0000
651 MALAISE 17 0.0000
652 RASH GENERALISED 1 0.0000
653 HAEMATOMA 1 0.0000
654 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
655 MUCOSAL INFLAMMATION 1 0.0000
656 SEDATION 1 0.0000
657 CHEST PAIN 7 0.0000
658 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
659 BLOOD BILIRUBIN INCREASED 1 0.0000
660 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
661 RESPIRATORY DISTRESS 1 0.0000
662 ANAPHYLACTIC REACTION 2 0.0000
663 TREMOR 6 0.0000
664 DIVERTICULITIS 1 0.0000
665 HAEMOPTYSIS 1 0.0000
666 NECK PAIN 2 0.0000
667 DEMENTIA 1 0.0000
668 SKIN EXFOLIATION 3 0.0000
669 TARDIVE DYSKINESIA 1 0.0000
670 OFF LABEL USE 31 0.0000
671 PAIN IN JAW 1 0.0000
672 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
673 BALANCE DISORDER 3 0.0000
674 PANCREATIC CARCINOMA 1 0.0000
675 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
676 BACK PAIN 8 0.0000
677 PAIN IN EXTREMITY 10 0.0000
678 PSYCHOTIC DISORDER 1 0.0000
679 DEVICE ISSUE 3 0.0000
680 LACRIMATION INCREASED 1 0.0000
681 STOMATITIS 2 0.0000
682 CONDITION AGGRAVATED 10 0.0000
683 VERTIGO 2 0.0000
684 FEELING HOT 2 0.0000
685 INJECTION SITE RASH 1 0.0000
686 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
687 NASOPHARYNGITIS 6 0.0000
688 PERIPHERAL SWELLING 5 0.0000
689 OROPHARYNGEAL PAIN 3 0.0000
690 GYNAECOMASTIA 1 0.0000
691 SWOLLEN TONGUE 1 0.0000
692 DYSPHAGIA 3 0.0000
693 NAUSEA 25 0.0000
694 PULMONARY EMBOLISM 3 0.0000
695 MOOD SWINGS 1 0.0000
696 GAIT DISTURBANCE 6 0.0000
697 DEATH 27 0.0000
698 HIP FRACTURE 1 0.0000
699 DRUG INTOLERANCE 3 0.0000
700 PRODUCT DOSE OMISSION 2 0.0000
701 EYE DISORDER 1 0.0000
702 VISUAL ACUITY REDUCED 1 0.0000
703 VIRAL INFECTION 1 0.0000
704 FUNGAL INFECTION 1 0.0000
705 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
706 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
707 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
708 CHEST DISCOMFORT 3 0.0000
709 HAEMORRHAGE 3 0.0000
710 COUGH 8 0.0000
711 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
712 THERAPY INTERRUPTED 2 0.0000
713 UNDERDOSE 2 0.0000
714 RESTLESSNESS 1 0.0000
715 AGITATION 2 0.0000
716 PRODUCT USE ISSUE 5 0.0000
717 ASTHMA 3 0.0000
718 HALLUCINATION 2 0.0000
719 BLOOD GLUCOSE INCREASED 5 0.0000
720 ACNE 2 0.0000
721 DEPRESSION 6 0.0000
722 ALOPECIA 5 0.0000
723 ARTHRITIS 2 0.0000
724 DISORIENTATION 1 0.0000
725 RASH 11 0.0000
726 HYPOTENSION 5 0.0000
727 CARDIAC FAILURE CONGESTIVE 2 0.0000
728 THROMBOSIS 2 0.0000
729 EXTRA DOSE ADMINISTERED 1 0.0000
730 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
731 BLINDNESS 1 0.0000
732 INFLUENZA LIKE ILLNESS 2 0.0000
733 DIZZINESS 12 0.0000
734 RHABDOMYOLYSIS 1 0.0000
735 OSTEOARTHRITIS 1 0.0000
736 RENAL FAILURE ACUTE 1 0.0000
737 PRURITUS 9 0.0000
738 DEVICE DISLOCATION 1 0.0000
739 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
740 ANGIOEDEMA 1 0.0000
741 LIVER DISORDER 1 0.0000
742 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
743 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
744 MEMORY IMPAIRMENT 3 0.0000
745 MUSCLE SPASMS 4 0.0000
746 TINNITUS 1 0.0000
747 COGNITIVE DISORDER 1 0.0000
748 ARRHYTHMIA 1 0.0000
749 PRODUCTIVE COUGH 1 0.0000
750 LUNG DISORDER 1 0.0000
751 HEART RATE INCREASED 2 0.0000
752 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
753 HYPOAESTHESIA 3 0.0000
754 DRY EYE 1 0.0000
755 LEUKOPENIA 1 0.0000
756 SOMNOLENCE 4 0.0000
757 BLOOD PRESSURE INCREASED 3 0.0000
758 SINUSITIS 2 0.0000
759 INFLAMMATION 1 0.0000
760 SPEECH DISORDER 1 0.0000
761 PARAESTHESIA 3 0.0000
762 DERMATITIS ATOPIC 1 0.0000
763 DRUG INTERACTION 3 0.0000
764 BRADYCARDIA 1 0.0000
765 RASH PRURITIC 1 0.0000
766 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
767 ARTHROPATHY 1 0.0000
768 MEDICATION ERROR 1 0.0000
769 WEIGHT INCREASED 4 0.0000
770 BLISTER 1 0.0000
771 MYALGIA 3 0.0000
772 FLATULENCE 1 0.0000
773 HEADACHE 11 0.0000
774 LETHARGY 1 0.0000
775 SURGERY 1 0.0000
776 NASAL CONGESTION 1 0.0000
777 IRRITABILITY 1 0.0000
778 VISUAL IMPAIRMENT 2 0.0000
779 LOSS OF CONSCIOUSNESS 2 0.0000
780 INFUSION RELATED REACTION 1 0.0000
781 INSOMNIA 4 0.0000
782 DRY SKIN 2 0.0000
783 INJECTION SITE PRURITUS 1 0.0000
784 BURNING SENSATION 1 0.0000
785 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
786 MOBILITY DECREASED 1 0.0000
787 BRONCHITIS 1 0.0000
788 INJECTION SITE SWELLING 1 0.0000
789 DRY MOUTH 1 0.0000
790 ARTHRALGIA 5 0.0000
791 TOXICITY TO VARIOUS AGENTS 2 0.0000
792 CEREBROVASCULAR ACCIDENT 2 0.0000
793 PRODUCT STORAGE ERROR 1 0.0000
794 GASTROINTESTINAL DISORDER 1 0.0000
795 ADVERSE DRUG REACTION 1 0.0000
796 SUICIDAL IDEATION 1 0.0000
797 ADVERSE EVENT 1 0.0000
798 BREAST CANCER 1 0.0000
799 MIGRAINE 1 0.0000
800 CHILLS 1 0.0000
801 FEELING ABNORMAL 2 0.0000
802 INJECTION SITE ERYTHEMA 1 0.0000
803 HYPERHIDROSIS 1 0.0000
804 PSORIASIS 1 0.0000
805 PRODUCT QUALITY ISSUE 1 0.0000
806 DRUG DOSE OMISSION 1 0.0000
807 URTICARIA 1 0.0000
808 MYOCARDIAL INFARCTION 1 0.0000
809 NO ADVERSE EVENT 1 0.0000
810 HYPERSENSITIVITY 1 0.0000
811 ERYTHEMA 1 0.0000
812 DRUG INEFFECTIVE 6 0.0000
813 INCORRECT DOSE ADMINISTERED 1 0.0000